CompletedNot Applicable

Short-term Psychodynamic Psychotherapy in Serious Physical Illness

Germany24 participantsStarted 2022-09-15

Plain-language summary

Life-threatening physical illness may powerfully re-activate existential conflict. There is little evidence to date on the effectiveness of relationship-focused therapies in this patient group.The aim of this study is to pilot a psychodynamic treatment for patients with advanced cancer and high psychological distress.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years and older * UICC stage IV solid tumor * Informed consent * Current physical condition that allows for at least 12 therapy sessions * Indication: Presence of a mental disorder with existential stress and limitations in coping capacity Exclusion Criteria: * Acute suicidality * Psychotic disorder (ICD-10: F2 diagnosis) * Substance dependence or abuse (ICD-10: F1 diagnosis) * Structural deficits that interfere with attending to regular appointments * Other psychotherapeutic treatment * Severe cognitive impairment * Severe physical impairment * Insufficient German to give informed consent and complete self-report questionnaires

What they're measuring

Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability)

Timeframe: up to 12-months follow-up

Acceptance

Timeframe: through study completion, an average of 6 months

Treatment adherence

Timeframe: through study completion, an average of 6 months

Therapeutic competence

Timeframe: through study completion, an average of 6 months

Treatment feasibility

Timeframe: through study completion, an average of 6 months

Trial details

NCT IDNCT05520281

SponsorUniversitätsklinikum Hamburg-Eppendorf

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-06

View on ClinicalTrials.gov More Malignant Neoplasm trials